DOCS
Doximity Inc

4,033
Loading...
Loading...
News
all
press releases
Can Doximity's New AI Suite Drive the Growth It Needs?
DOCS reports stronger Q1 results and is betting on its new AI suite -- Scribe, GPT, and Pathway -- to drive its next growth phase.
Zacks·8d ago
News Placeholder
More News
News Placeholder
Doximity (DOCS) Stock Sinks As Market Gains: What You Should Know
Doximity (DOCS) closed the most recent trading day at $70.64, moving 3.43% from the previous trading session.
Zacks·9d ago
News Placeholder
HIMS vs. DOCS: Which Digital Health Platform Is a Better Investment?
Hims & Hers and Doximity are transforming digital health, but which leads in earnings growth and platform expansion? Let's see.
Zacks·14d ago
News Placeholder
Do Options Traders Know Something About Doximity Stock We Don't?
Investors need to pay close attention to DOCS stock based on the movements in the options market lately.
Zacks·17d ago
News Placeholder
Hims & Hers Expands Care Ecosystem via Global and Digital Innovation
HIMS is scaling globally with AI-powered care, new treatments and an $870 million boost to expand its digital ecosystem.
Zacks·18d ago
News Placeholder
Doximity (DOCS) Exceeds Market Returns: Some Facts to Consider
Doximity (DOCS) closed at $73.6 in the latest trading session, marking a +1.28% move from the prior day.
Zacks·22d ago
News Placeholder
Doximity (DOCS) Increases Despite Market Slip: Here's What You Need to Know
Doximity (DOCS) closed at $71.03 in the latest trading session, marking a +1.1% move from the prior day.
Zacks·28d ago
News Placeholder
HIMS' Personalized Wellness Platform Expands Preventive Care Access
Hims & Hers expands its personalized wellness platform, aiming to reshape preventive care through tech-driven, holistic solutions.
Zacks·1mo ago
News Placeholder
Hims & Hers Drives the Consumer-Centric Transformation in Digital Care
HIMS leverages its consumer-first telehealth model, AI-driven personalization and global expansion plans to outpace industry growth.
Zacks·2mo ago
News Placeholder
DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down
Doximity beats first-quarter fiscal 2026 estimates with double-digit revenue growth and lifts its full-year forecast.
Zacks·2mo ago

Latest DOCS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.